India's Sun Pharma acquires U.S.-based Pharmalucence
MUMBAI, July 16
MUMBAI, July 16 (Reuters) - Sun Pharmaceutical Industries Ltd, India's third-largest generic drugmaker by sales, said on Wednesday it had acquired U.S.-based Pharmalucence Inc, which has sterile injectable capacity and research capabilities.
Financial details of the deal were not disclosed. (Reporting by Sumeet Chatterjee; Editing by Prateek Chatterjee)
Trending On Reuters
We are living longer but not creating financial plans to keep pace. Advisers give tips on how to make sure you don’t outlive your money. Video